comparemela.com
Home
Live Updates
Myeloma Disease Working Group - Breaking News
Pages:
Latest Breaking News On - Myeloma disease working group - Page 1 : comparemela.com
Vial Announces the Addition of Dr Marc Hoffmann from the University of Kansas Medical Center to their Oncology CRO Scientific Advisory Board
/PRNewswire/ Vial, a tech-enabled CRO providing next-generation clinical trial management services, announced the addition of Marc Hoffmann, MD, to Vial s.
Richard mccormick jr
Marc hoffmann
University of kansas
Vial technology platform
Cancer center
Lymphoma myeloma disease working group
Vial contract research organization
Scientific advisory
Medical director
Quality improvement
Myeloma disease working group
Contract research organization
Therapeutic areas
vimarsana © 2020. All Rights Reserved.